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EXPERIMENTALLY INDUCED DERMATOMYCOSES
AT RATS AND TREATMENT WITH
LAVANDULA ANGUSTIFOLIA ESSENTIAL OIL
ABSTRACT: The in vivo evaluation of antifungal activity of the Lavandula angusti-
folia essential oil was made on two-month old male Wistar rats. We examined the therape-
utic potency against experimentally induced dermatomycoses in rats, using the most fre-
quent dermatomycetes, Trichophyton mentagrophytes. The therapeutic efficacy of 1% solu-
tion of essential oil as well as commercial preparation-bifonazole, was evaluated. During
the 13-day observation period the oil-treated animals were cured completely.
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INTRODUCTION
During the past several years numerous antifungal agents have been for-
mulated and evaluated for use in the management of fungal infections (R y a n,
1994). The emerging resistance of microorganisms to some synthetic antibio-
tics makes it necessary to continue the search for new antimicrobial substan-
ces. With the increasing acceptance of traditional medicine as an alternative
form of health care, the searching for active compounds in medicinal plants
became very important. Human infection diseases have been markedly increa-
sing during the past ten years, especially in immunocompromised patients.
Consequently, as high as 10% percent of hospital acquired systemic infections
are caused by fungi.
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The increasing resistance of human pathogens to current commercial
drugs is a serious medical problem, and has resulted in the need for novel anti-
microbial agents.
Natural products derived from plants have traditionally been used in
ethnomedicine. In Western medicine, substances derived from higher plants
constitute ca. 25% of prescribed medicines and 74% of the 121 bioactive
plant-derived compounds currently in worldwide use, which were identified
via research based on leads from ethnomedicine (S o k m e n et al., 1999). Re-
cent researches showed that higher plants may serve as promising sources of
novel antimycotics with no side effects on human and animals (C l a r k and
H u f f o r d, 1993). Essential oils play a great role in these investigations. Stu-
dies over the last hundred years have demonstrated the antimicrobial properties
of several common spice oils (B u l l e r m a n et al., 1977). M a r u z z e l a
and B a l t e r (1959) found that 100 essential oils out of 119 spice oils, tested,
possessed an antagonist effect an at least one of 12 pathogenic fungi, and 50
of these samples showed a wide spectrum of activities against all fungi tested.
The purpose of this study was to investigate Lavandula angustifolia es-
sential oil for potential antifungal activity. The selection of the plant for evalu-
ation was based on traditional use of this plant in treatment of various infec-
tion diseases (J a n å i ã et al., 1995; K o v a å e v i ã, 2000).
MATERIAL AND METHODS
Plant material
Lavandula angustifolia was collected during May in 1999 at the fields of
the Institute for Medicinal Plant Research in Panåevo, Belgrade, Serbia. Vou-
cher specimens (No. 04071970 and 25072) were deposited in the Herbarium of
Institute of Botany and Botanical Garden “Jevremovac", University of Bel-
grade.
Isolation of essential oils
Composition of essential oils was investigated using analytical GC/FID
and GC/MS techniques. For this purpose, HP 5890 series II gas chromato-
graph, equipped with split-splitless injector, fused silica capillary column (25
m x 0.32 mm), coated with cross-linked methyl silicone gum (0.5 mm film
tickness), and FID was employed. Essential oil solutions in ethanol (1%) were
injected in split mode (1:30). Injector was heated at 250°C, FID at 300°C,
while column temperature was linearly programmed from 40—280°C (4°C/min).
GC/MS analysis was carried out on a HP-GCD, equipped with split-split-
less injector, fused silica capillary column (50 m x 0.2 mm) PONA, coated
with cross-linked methyl silicone gum (0.5 mm film tickness) and mass selec-
tive detector. The chromatographic conditions were as above. Transfer line
(MSD) was heated at 280°C. EMS spectra (70 eV) were acquired in scan
mode in m/e range 40—300.
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The identification of individual constituents was carried out by compari-
son of their retention times with those of analytical standards, and by compu-
ter searching, matching the mass spectral data with those held in Wiley/NBS
library of mass spectra. For quantification purposes area percent reports obtai-
ned by FID were used.
Bioassays
Toxicology: in order to determine the non toxic concentration of the es-
sential oil investigated, we used male Wistar rats (17—24 g). 0.5 ml of pre-
pared stock solution of essential oil, and a component diluted in ethanol
(0.01—1% v/v) were injected intraperitoneal in male Wistar rats (Pharmaco-
pea Jugoslavica, 1984). The concentration which was not toxic for the animals
investigated, was used for further investigation.
Animals. Two-month-old male Wistar rats were maintained at 21°C, and
were allowed access to feed and water ad libitum.
In vivo Fungitoxicity Assay. The in vivo investigation of antifungal acti-
vity of Lavandula angustifolia essential oil was made according to A d a m et
al., (1998). We used Trychophyton mentagrophytes as an infectious agent. The
organism was isolated from patients at the Center for Preventive Medicine,
MMA, Belgrade, Serbia.
The micromycetes were maintained on Sabouraud Dextrose Agar (SDA),
containing 40 g of glucose, 10 g of agar and 10 g of peptone in 1 l of distil-
late H2O. The cultures were stored at +4°C, and subcultured once a month
( B o o t h, 1971).
On the back of each animal, the areas of 4 cm2 were cleaned and depila-
ted. The infectious inoculum was prepared from a 7-day-old culture of Trycho-
phyton mentagrophytes. The inoculum was applied on the animals' back im-
mediately after the depilation and left for 3 days. The establishment of active
infection was confirmed on the 4th day, by isolation of the pathogens from
skin scales cultured from infected loci on SDA plates, containing 100 units/ml
of penicillin and streptomycin. Infections were, also, confirmed by visual
examination of animals. In the animals in which active infections were confir-
med, treatment was initiated on the 5th day post inoculation and continued
until complete recovery from the infection was achieved. The ointments con-
tained 1% (v/v) of essential oil and component mixed in petroleum jelly. The
commercial fungicide, bifonazole, was used as a control. Animals were treated
once a day, and the infected areas were scored visually for inflammation and
scaling as, well as for the presence of the pathogens by cultivating skin scales
from infected loci in SDA plates containing 100 units/ml of penicillin and
streptomycin, each day.
RESULTS AND DISCUSSION
The qualitative and quantitative composition of the essential oils of La-
vandula angustifolia was presented in Table 1. The essential oil is characteri-
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zed with high content of linalool (27.21%) and linalool acetate (27.54%),
while limonene is presented with 8.5%.
Tab. 1 — Chemical composition of Lavandula angustifolia essential oil
Components % RI
tricyclene 0.04 301
-thujene 0.58 307
-pinene 0.19 319
p-cymene 0.25 471
limonene 8.50 481
1,8-cineole 3.34 485
cis-linalool oxide 2.44 574
camphenylon — 594
fenchon 0.59 605
linalool 27.21 632
endo-fenchol 0.09 664
camphor 1.07 734
borneol 2.51 789
terpine-4-ol 2.09 820
p-cimene-8-ol — 837
-terpineol 4.30 852
myrtenal — 864
fenchyl acetate — 930
carvon — 984
linalool acetate 27.54 1023
bornyl acetate 0.06 1099
lavandulyl acetate 6.54 1111
trans-pinokarvyl acetate 0.16 1135
neryl acetate 2.02 1303
geranyl acetate 2.95 1352
-selinene — 1608
-cadinene — 1700
viridiphlorol — 1859
Total 97.47
* In elution order on DB-5 column (6)
The essential oil was tested for its potential toxicological activity in 0.1%
and 1% (v/v) solutions in ethanol and petroleum jelly, separately. There is no
toxicological activity for 0.1% solutions on the rats. However, in this work the
animals were treated topically, and according to the literature (A d a m et al.,
1998), for further investigation 1% solutions were used.
The therapeutic efficacy of the ointments was evaluated daily by macro-
scopic examination of lesions, and by screening for the presence of the infec-
tions by culturing skin scales from the infected area. The lesions were treated
as cured only when the infected area was free of macroscopic lesions, and
when the cultures were negative.
First symptoms (small vesicles) at the rats inoculated with T. menta-
grophytes were observed on the 5th day of the experiment, while, later (8th
day), these were exhibiting in bloody wounds, 20 mm in diameter. We started
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with the treatment on the 5th day of the experiment. On the 13th day of the tre-
atment with solution of L. angustifolia essential oil, the rats were completely
cured, there were no visually observed symptoms and the cultures were nega-
tive. Animals treated with the commercial drug, bifonazole, were cured after
15 days of treatment.
During the 13-day observation period the treated animals were cured
completely. It should be noted that in many cases macroscopic lesions disap-
peared long before the elimination of the infectious agent, indicating that long
treatment periods of application and evaluation are necessary (A d a m et al.,
1998). It is normal because dermatomycetes infections typically resolve on
their own over a variable time period (18 months to 4 years) depending on the
immune response. Many of dermatomycetes rarely cause strong inflammatory
reactions, making it very difficult for the immune system to recognize and eli-
minate the fungus.
The animals treated with the commercial drug, bifonazole, were cured
after 15 days of treatment.
From the above results it can be concluded that essential oil of Lavandula
angustifolia has a good therapeutic and antifungal effect in vivo, and could re-
present possible alternative for the treatment of patients infected by derma-
tomycetes. Even more, because of the side effects of commercial fungicides
and possible resistance of pathogens to the synthetic mycotics, the preparation
with natural products has an advantage in the treatment of disseases caused by
fungi.
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Rezime
Infekcije qudi uzrokovane gqivama su u znatnom porastu u posledwih 10
godina, posebno kod imunokompromitovanih pacijenata. Åak 10% infekcija kod
hospitalizovanih pacijenata izazvano je gqivama. S obzirom da je pojava rezi-
stencije na komercijalne fungicide uåestala, javqa se potreba za novim alter-
nativnim antifungalnim agensima. Prirodni produkti dobijaju sve veãi znaåaj
u tretmanu infektivnih oboqewa zbog svog netoksiånog karaktera, visoke bio-
degradibilnosti i efikasnosti. Etarska uqa izolovana iz biqaka pokazuju veo-
ma dobru antimikrobnu aktivnost.
Eksperimentalna dermatomikoza kod Wistar pacova u ovom radu izazvana je
dermatomicetom Trichophyton mentagrophytes. Prvi simptomi pojavili su se na-
kon 5 dana od inokulacije. Tremtan etarskim uqem vrste Lavandula angustifolia,
1% rastvorom poåeo je odmah nakon pojave prvih simptoma. Poboqšawe simp-
toma primeãeno je nakon dva dana tretmana, a posle 13 dana od poåetka tretmana
ÿivotiwe su u potpunosti izleåene, na SDA podlogama nije bilo zabeleÿeno
prisustvo patogena. Bifonazol je doveo do izleåewa nakon 15 dana tretmana.
Etarsko uqe Lavandula angustifolia pokazalo je izuzetno jak antifungalni poten-
cijal u tretmanu eksperimentalno indukovane dermatomikoze kod pacova, boqe
od komercijalnog mikotika, bifonazola, koji je korišãen kao pozitivna kon-
trola.
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